0001209191-22-006797.txt : 20220203
0001209191-22-006797.hdr.sgml : 20220203
20220203163039
ACCESSION NUMBER: 0001209191-22-006797
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220201
FILED AS OF DATE: 20220203
DATE AS OF CHANGE: 20220203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Betz Stephen F.
CENTRAL INDEX KEY: 0001886575
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38583
FILM NUMBER: 22588861
MAIL ADDRESS:
STREET 1: 10222 BARNES CANYON ROAD
STREET 2: BUILDING 2
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Crinetics Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001658247
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263744114
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10222 BARNES CANYON ROAD, BLDG. #2
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-450-6464
MAIL ADDRESS:
STREET 1: 10222 BARNES CANYON ROAD, BLDG. #2
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-01
0
0001658247
Crinetics Pharmaceuticals, Inc.
CRNX
0001886575
Betz Stephen F.
C/O CRINETICS PHARMACEUTICALS, INC.
10222 BARNES CANYON ROAD, BLDG 2
SAN DIEGO
CA
92121
0
1
0
0
Chief Scientific Officer
Common stock
2022-02-01
4
S
0
3123
18.79
D
126706
D
The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 30 days prior to the trading date.
Includes 954 shares acquired under the Issuer's Employee Stock Purchase Plan in November 2021 by the Reporting Person.
/s/ Marc Wilson, as attorney-in-fact
2022-02-03